CureVac – a German pharmaceutical company – settled a long-running patent dispute with rival BioNTech and Pfizer in the US on ...

The complicated legal wrangling has been brought to a close after CureVac and BioNTech settled their mRNA patent litigation ...

Fewer Kentucky kindergarten students have received the vaccines required to attend school, and data from the state's School ...

American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain’s GSK and Germany’s CureVac $740 million plus royalties to settle US legal disputes over Covid-19 vaccines, ...

Robert F. Kennedy Jr., the HHS Secretary of the US, despite a long history of the contray, now often pretends to be not against vaccinations. Yet, his recent actions depict an entirely different ...

The Trump Administration said this week it is pulling half a billion dollars from U.S. government-funded research projects to ...

On Wednesday, after the news that the HHS was terminating crucial vaccine development projects worth $500 million, Cassidy called the decision "unfortunate" in a post on the X social network. That’s a ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

U.S. Health Secretary Robert F. Kennedy Jr. incorrectly argued mRNA vaccines are ineffective to justify the Department of ...

Health Secretary Robert F. Kennedy Jr. announced plans on Tuesday to cancel 22 mRNA vaccine development contracts totaling nearly $500 million. The move follows a “comprehensive review of mRNA-related ...

German drugmaker CureVac and GSK reached an agreement with BioNTech and Pfizer on Thursday to resolve a years-long patent ...

The U.S. Department of Health and Human Services announced a significant shift in vaccine funding, spearheaded by Health ...